Biomemory Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 52

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 21

Biomemory General Information

Description

Developer of data storage drives designed to offer bio-digital data storage for large companies and administrations. The company's drives are low-cost and have a biobased system for storing large amounts of computer data on long deoxyribonucleic acid strands rather then solid state drive or magnetic tape that is stable at ambient temperature with no energetic input and carbon dioxide emission, enabling researchers to get an ultimate storage media durable for thousands of years.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5 impasse Reille
  • 75014 Paris
  • France
Primary Industry
Storage (IT)
Other Industries
Other Devices and Supplies
Environmental Services (B2B)
Corporate Office
  • 5 impasse Reille
  • 75014 Paris
  • France

Biomemory Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomemory Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
7. Early Stage VC (Series A) 13-Nov-2024 Completed Generating Revenue
6. Seed Round 23-Mar-2023 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2022 Completed Startup
4. Accelerator/Incubator 01-Jan-2022 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator 13-Sep-2021 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Biomemory’s complete valuation and funding history, request access »

Biomemory Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ABSA A
S-2 Shares
To view Biomemory’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Biomemory Patents

Biomemory Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026125266-A1 Tagged digital data-encoding nucleic acid and method for producing a tagged digital data-encoding nucleic acid Pending 13-Dec-2024
EP-4820908-A1 Molecular digital data storage using nucleic acids Pending 04-Dec-2023
WO-2025120011-A1 Molecular digital data storage using nucleic acids Inactive 04-Dec-2023 G11C13/0019

Biomemory Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomemory Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
La French Tech Accelerator/Incubator
ADNEXUS (Paris) Corporate Venture Capital Minority
Ah Capital Angel Group Minority
Audacia Growth/Expansion Minority
Crédit Mutuel Equity Growth/Expansion Minority
You’re viewing 5 of 21 investors. Get the full list »

Biomemory Acquisitions (1)

Biomemory’s most recent deal was a Merger/Acquisition with Catalog (Biotechnology). The deal was made on 05-Mar-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Catalog (Biotechnology) 05-Mar-2026 Merger/Acquisition Biotechnology
To view Biomemory’s complete acquisitions history, request access »

Biomemory FAQs

  • When was Biomemory founded?

    Biomemory was founded in 2021.

  • Where is Biomemory headquartered?

    Biomemory is headquartered in Paris, France.

  • What is the size of Biomemory?

    Biomemory has 52 total employees.

  • What industry is Biomemory in?

    Biomemory’s primary industry is Storage (IT).

  • Is Biomemory a private or public company?

    Biomemory is a Private company.

  • What is Biomemory’s current revenue?

    The current revenue for Biomemory is .

  • How much funding has Biomemory raised over time?

    Biomemory has raised $23.4M.

  • Who are Biomemory’s investors?

    La French Tech, ADNEXUS (Paris), Ah Capital, Audacia, and Crédit Mutuel Equity are 5 of 21 investors who have invested in Biomemory.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process